The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Privia Health Group Inc (NASDAQ: PRVA) closed at $22.90 down -2.47% from its previous closing price of $23.48. In other words, the price has decreased by -$2.47 from its previous closing price. On the day, 0.73 million shares were traded. PRVA stock price reached its highest trading level at $23.78 during the session, while it also had its lowest trading level at $22.86.
Ratios:
For a deeper understanding of Privia Health Group Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.65. For the most recent quarter (mrq), Quick Ratio is recorded 1.86 and its Current Ratio is at 1.86. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On October 11, 2024, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $23.KeyBanc Capital Markets initiated its Overweight rating on October 11, 2024, with a $23 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 01 ’25 when Mehrotra Parth bought 17,365 shares for $23.08 per share.
Mehrotra Parth bought 15,100 shares of PRVA for $352,244 on Apr 30 ’25. On Apr 30 ’25, another insider, Mountcastle David, who serves as the Officer of the company, bought 3,445 shares for $23.33 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRVA now has a Market Capitalization of 2778067712 and an Enterprise Value of 2322456832. As of this moment, Privia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 200.17, and their Forward P/E ratio for the next fiscal year is 65.86. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.21. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.60 while its Price-to-Book (P/B) ratio in mrq is 4.34. Its current Enterprise Value per Revenue stands at 1.338 whereas that against EBITDA is 95.771.
Stock Price History:
The Beta on a monthly basis for PRVA is 0.87, which has changed by 0.2219851 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, PRVA has reached a high of $26.04, while it has fallen to a 52-week low of $15.92. The 50-Day Moving Average of the stock is -3.07%, while the 200-Day Moving Average is calculated to be 8.59%.
Shares Statistics:
For the past three months, PRVA has traded an average of 823.63K shares per day and 549080 over the past ten days. A total of 120.31M shares are outstanding, with a floating share count of 107.44M. Insiders hold about 11.44% of the company’s shares, while institutions hold 94.80% stake in the company. Shares short for PRVA as of 1744675200 were 3483511 with a Short Ratio of 4.23, compared to 1741910400 on 4427103. Therefore, it implies a Short% of Shares Outstanding of 3483511 and a Short% of Float of 5.2299999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
